SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bret Emmett who wrote (480)	6/12/1998 10:32:00 PM
From: Prospector	of 5402

message from DR DREES I received a package from DR Drees today I am posting articles in it as I have time.. post #421 post #418 I have posted so far. I am sending you Wall Street Journal reports on our sometime competition. You will see that they keep striking out. Their Technology is very complex and expensive Baxter, Northfield and Hemosol depend on outdated red blood cells which are in very short supply. Biopure uses Bovine or cows blood from a herd of specially maintained cows. If they ever get FDA approval they would need 800,000 cows standing around in pastures to supply the market for humans in addition to the low price/low profit cat and dog market. We did a market study on the pet market and found it not worth while. As you can see Baxter, Somatogen, Biopure and Alliance have lost their partners in the past year. DR Chang says concentrated efforts to develop blood substitutes only started after 1986 because of HIV. There was serious development in the 60's on the first Generation of PHER-02 . Thus we have a big jump on the others and our product is second generation. Prospector (don't mind the spellin I'm doin the best I can) you know how dr write it's hard to read.. so if something don't make sense it's my fault..

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next